One Dose Of Ad5-nCoV Covid Vax Is Safe, Effective: The Lance

One dose of Ad5 nCoV Convidecia a Covid 19 vaccine developed in China is 57 5 per cent effective against symptomatic Covid 19 and 91 7 per cent effective against severe Covid 19 disease beginning 28 days post vaccination finds a new study

Related Keywords

Dalhousie , New Brunswick , Canada , Mexico , Argentina , China , Beijing , Chile , Russia , Pakistan , Scott Halperin , Cansino Biologics Inc , Dalhousie University , Institute Of Biotechnology , Cansino Biologics , Beijing Institute , Convidecia Covid19 Vaccine ,